It may even protect against health conditions like overeating, obesity, and diabetes, suggests animal research
To note, Wegovy (semaglutide) is a higher dose semaglutide formulation which has been approved by the TGA for chronic weight management at a maximum dose of 2.4 mg weekly
Using mouse models implanted with PTC tumors and cell cultures, researchers found that semaglutide significantly reduced tumor size
The two treatments operate through completely separate mechanisms: semaglutide acts on GLP-1 receptors in pancreatic, gastrointestinal, and central nervous system tissues, whilst botulinum toxin blocks acetylcholine release at peripheral nerve terminals
Novo Nordisks Wegovy is available as multiple-dose pre-filled pens that deliver a preset dose for once-weekly dosing, while Ozempic is available as multiple-dose pre-filled pens for single-patient use, designed for once-weekly dosing